BSECompany Update11 Aug 2026 · 11 Aug 2026, 07:56 pm
Investor Meet
Biocon Ltd · 532523
✦ AI SummaryOrder Win
Biocon Ltd has scheduled a meeting with analysts/institutional investors as part of the Motilal Oswal 22nd Annual Global Investor Conference on August 17, 2026, in Mumbai. The meeting is subject to change due to exigencies. The company will not disclose any unpublished price-sensitive information during the meeting.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
e3b7487c-0a30-4bc8-a08a-eee529c650e9.pdf
View document text
Biocon Limited
20th KM, Hosur Road
Electronic City
Bangalore 560 100, India
T 91 80 2808 2808
F 91 80 2852 3423
CIN : L24234KA1978PLC003417
www.biocon.com
BIO/SECL/TG/2026-27/59
August 11, 2026
To, To,
The Secretary The Secretary
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services Corporate Communication Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai – 400 001 Mumbai – 400 051
Scrip Code - 532523 Scrip Symbol - BIOCON
Dear Sir/ Madam,
Sub: Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)
Pursuant to Regulation 30(6) of the SEBI Listing Regulations, we wish to inform you that the Management
of the Company is scheduled to meet with the Analyst(s)/Institutional Investor(s) as per the details given
below:
Type of
Date Event Venue
Interaction
1x1/Group/In-
17-Aug-26 Motilal Oswal 22nd Annual Global Investor Conference Mumbai
Person
Note: The above-mentioned schedule is subject to change due to exigencies on the part of Investors/Company.
Kindly note that the Company will not disclose any Unpublished Price Sensitive Information (UPSI) during
the analyst(s)/ investor(s) meeting.
The above information will also be available on the website of the Company at www.biocon.com.
We request you to kindly take the above information on record.
Thanking You,
Yours faithfully,
For Biocon Limited
Rajesh U. Shanoy
Company Secretary and Compliance Officer
Membership No.: ACS 16328